SunWay 2020 annual revenue was 314 million and will be listed on Taiwan Emerging Stock Market on January 18, 2021.

On January 12, SunWay Biotech Co., LTD. (1271) was invited by Fubon Securities Co., Ltd. to participate in the institutional investor conference. John Pan, President of SunWay Biotech, introduced two main ingredients-ANKASCIN 568-R and Vigiis 101-LAB probiotics and their application, and announced that SunWay Biotech will be listed on Taiwan Emerging Stock Market on January 18, 2021.

Back to List

ADD.

No.139, Xing’ai Rd., Neihu Dist., Taipei 11494

TEL.

+886-2-2792-9568

ADD.

6F., No. 2, Aly. 36, Ln. 26, Ruiguang Rd., Neihu District, Taipei City, 114 Taiwan

TEL.

+886-2-2790-1555

What You Say

Get in touch to explore new possibilities. Our team is ready to connect with you.

Name

Phone

Company

Country

How do you hear from us

Interested

Message

Bora Pharmaceuticals USA needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, please review our Privacy Policy.